Anti-fibrotic agents (e.g., Pirfenidone, Nintedanib)
Treatment used for 1 condition
Total Trials
4
Total Participants
0K
Avg Effectiveness
25%
Avg Safety Score
35%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.